Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Alembic Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (367)
ARTG (144)
Prescription medicine registration (10)

Date

2025 (83)
2024 (10)
2023 (245)
2022 (10)
2021 (84)
2020 (22)
2019 (2)
2018 (17)
2017 (17)
2016 (3)
2015 (11)
2013 (11)
2012 (6)

Search

Sponsor content

521 result(s) found, displaying 121 to 130

DESVENLAFAXINE ALEMBIC desvenlafaxine 100 mg extended release tablet blister pack (379751)

10 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DESVENLAFAXINE ALEMBIC desvenlafaxine 100 mg extended release tablet blister pack.
RIVALEM (Alembic Pharmaceuticals Australia Pty Ltd)

29 August 2023

Prescription medicine registration

Active ingredients: Rivaroxaban.
VIMOLAC lacosamide 100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
DEFERASIROX AGHL deferasirox 360 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ AGL 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

16 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN AGH candesartan cilexetil 4 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDELEM candesartan cilexetil 32 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
TELMISARTAN APA telmisartan 40mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
OLMESARTAN HCT AGH 20/25 olmesartan medoxomil/hydrochlorothiazide 20/25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
OLMESARTAN AGH olmesartan medoxomil 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.